Company Profiles

driven by the PitchBook Platform

RaNA Therapeutics

Description

Developer of next generationRNA-targeted medicines created to change the treatment paradigm through RNA activation. The company is selectively activating gene expression to increase protein levels in the body for therapeutic benefit, enabling the activation of the vast majority of genes, making its platform applicable to a broad range of diseases that have never had treatment options before now.

2010

Founded

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$51M

Latest Deal Amount

$141M

Total Amount Raised

Description

Developer of next generationRNA-targeted medicines created to change the treatment paradigm through RNA activation. The company is selectively activating gene expression to increase protein levels in the body for therapeutic benefit, enabling the activation of the vast majority of genes, making its platform applicable to a broad range of diseases that have never had treatment options before now.

Website:

www.ranarx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

200 Sidney Street Suite 310 Cambridge, MA 02139United States +1 (617) 945-7361
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore RaNA Therapeutics's full profile, request a free trial.

RaNA Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

RaNA Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

RaNA Therapeutics Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Atlas VentureVenture CapitalMinority000 0000000 0000
Brookside CapitalVenture CapitalMinority000 0000000 0000
Fidelity InvestmentsMutual FundMinority000 0000000 0000
Leerink PartnersInvestment BankMinority000 0000000 0000
Merck VenturesCorporate Venture CapitalMinority000 0000000 0000
Atlas Venture Venture Capital
Brookside Capital Venture Capital
Fidelity Investments Mutual Fund
Leerink Partners Investment Bank
Merck Ventures Corporate Venture Capital

RaNA Therapeutics Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Ronald Renaud Jr.Chief Executive Officer and Board Member
Thomas McCauley Ph.DChief Scientific Officer
Jeannie Lee Ph.DCo-Founder & Scientific Advisor
Balkrishen Bhat Ph.DVice President, Chemistry
Brian FentonVice President, Corporate Development
Ronald Renaud Jr. Chief Executive Officer and Board Member
Thomas McCauley Ph.D Chief Scientific Officer
Jeannie Lee Ph.D Co-Founder & Scientific Advisor
Balkrishen Bhat Ph.D Vice President, Chemistry
Brian Fenton Vice President, Corporate Development

RaNA Therapeutics Board Members (10)

NameRepresentingRoleSinceContact
Info
Ankit Mahadevia MDAtlas VentureAdvisor000 0000
Brian Gallagher Ph.DSR OnePartner000 0000
Daniel LynchSelfExecutive Chairman000 0000
Iain Dukes Ph.DSelfBoard Member000 0000
Jasper Bos Ph.DMerck VenturesVice President & Head of Healthcare000 0000
Ankit Mahadevia MD Advisor Atlas Venture
Brian Gallagher Ph.D Partner SR One
Daniel Lynch Executive Chairman Self
Iain Dukes Ph.D Board Member Self
Jasper Bos Ph.D Vice President & Head of Healthcare Merck Ventures
Request full access to PitchBook